US Patent Issued to PHOENIX MOLECULAR DESIGNS on Aug. 5 for "Crystalline forms of an RSK inhibitor" (British, American, Canadian Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,245, issued on Aug. 5, was assigned to PHOENIX MOLECULAR DESIGNS (Vancouver, Canada).

"Crystalline forms of an RSK inhibitor" was invented by Richard Winnike (Woodbine, Md.), Elaine McPherson (Edinburgh, Great Britain), Erik Flahive (San Diego), Sandra E. Dunn (Vancouver, Canada) and Jonathan Loughrey (Edinburgh, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are crystalline forms of (R)-N-(1-(4-aminobenzyl)-1H-pyrazol-4 -yl)-9-methyl-6-oxo-6,7,8,9-tetrahydropyrido [3',2': 4,5]-pyrrolo [1,2-a]pyrazine-2-carboxamide hydrochloride and solvates thereof; pharmaceutical compositions and use thereof in treating cancer such as...